Photosensitivity Trial. A Randomized, Double-blind, Double Dummy, Placebo- and Positive Controlled Phase I Trial to Evaluate the Photosensitizing Potential of TMC435 in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 03 May 2013
At a glance
- Drugs Ciprofloxacin; Simeprevir
- Indications Bacterial infections; Hepatitis C
- Focus Adverse reactions
- Sponsors Janssen R&D Ireland
- 04 Apr 2012 Results will be presented at EASL-2012 according to a Medivir media release.
- 09 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 18 Nov 2010 Planned end date changed from 1 Mar 2011 to 1 Apr 2011 as reported by ClinicalTrials.gov.